FITCHBURG, MA--(Marketwire - November 14, 2008) - Arrhythmia Research Technology, Inc. (the "Company") (AMEX: HRT) (NYSE Alternext US: HRT) and its wholly owned subsidiary Micron Products, Inc. ("Micron") reported total revenue of $5,838,000 and net income of $68,000 for the quarter ended September 30, 2008 compared to total revenue of $4,458,000 and net income of $421,000 for the same quarter of 2007. Basic net income per share for the three months ended September 30, 2008 decreased to $0.03 per share from $0.16 per share for the same period in 2007.
